Jan Drappatz
Experienced in Dysembryoplastic Neuroepithelial Tumors (DNET)
Experienced in Dysembryoplastic Neuroepithelial Tumors (DNET)
5115 Centre Avenue, Hillman Cancer Center, 
Pittsburgh, PA 

Overview

Jan Drappatz, MD, is a neuro-oncologist, an associate professor at the University of Pittsburgh School of Medicine, and the director of the Neuro-oncology program at UPMC. Dr. Drappatz specializes in the treatment of primary and metastatic brain tumors and neurologic complications of cancer.

Dr. Drappatz is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

His clinical research consists of co-authoring 80 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Johannes Gutenberg-University Of Mainz
Residency
Boston Medical Center
Specialties
Neurology
Licenses
Psychiatry & Neurology in PA
Board Certifications
American Board Of Psychiatry And Neurology
Fellowships
Dana Farber Cancer Institute
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Upmc St Margaret
Indiana Regional Medical Center
Upmc Passavant
Languages Spoken
English
French
German
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Golden Rule
  • INSURANCE PLAN
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

UPMC Hillman Cancer Center
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232

Additional Areas of Focus

Dr. Drappatz has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase 2 Study of the PARP Inhibitor Olaparib (AZD2281) in IDH1 and IDH2 Mutant Advanced Solid Tumors
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
View 7 Less Clinical Trials
Similar Doctors
Advanced in Dysembryoplastic Neuroepithelial Tumors (DNET)
Advanced in Dysembryoplastic Neuroepithelial Tumors (DNET)
5150 Centre Ave, 2nd Floor, 
Pittsburgh, PA 
 (0.1 miles away)
Languages Spoken:
English

Frank Lieberman is a Neurologist in Pittsburgh, Pennsylvania. Dr. Lieberman is rated as an Elite provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.

Riddhi Patira
Advanced in Dysembryoplastic Neuroepithelial Tumors (DNET)
Advanced in Dysembryoplastic Neuroepithelial Tumors (DNET)

UPMC Neurological Institue - Children's South

205 Millers Run Road, 
Bridgeville, PA 
 (11.8 miles away)
Languages Spoken:
English, Gujarati , Hindi
Accepting New Patients
Offers Telehealth

Riddhi Patira, MD, is a neurologist certified in neuropsychiatry and behavioral neurology by the American Board of Psychiatry and Neurology. She is investigator of the Alzheimer’s Disease Research Center and leader of the Frontotemporal Dementia Consortium. She is also an assistant professor of Neurology at the University of Pittsburgh School of Medicine. She received her medical degree from Pandit Ravishankar Shukla University and completed her residency at Temple University, followed by her fellowship at the University of Pennsylvania. Dr. Patira’s clinical and research interests focus on the various cognitive disorders, especially neurodegenerative diseases such as Alzheimer’s disease, frontotemporal dementia, and other types of dementia. She has published numerous articles in peer-reviewed journals and is a member of the American Academy of Neurology. View the full list of Dr. Patira’s publications on PubMed. https://pubmed.ncbi.nlm.nih.gov/?term=Patira%2C+R. Dr. Patira is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). Her top areas of expertise are Apraxia, Dysembryoplastic Neuroepithelial Tumors (DNET), Memory Loss, and Primary Progressive Aphasia.

Experienced in Dysembryoplastic Neuroepithelial Tumors (DNET)
Neurology | Sleep Medicine
Experienced in Dysembryoplastic Neuroepithelial Tumors (DNET)
Neurology | Sleep Medicine

Allegheny Clinic

420 E N Ave, Suite 206, 
Pittsburgh, PA 
 (3.4 miles away)
Languages Spoken:
English
Offers Telehealth

Mihaela Nowak is a Neurologist and a Sleep Medicine provider in Pittsburgh, Pennsylvania. Dr. Nowak is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). Her top areas of expertise are Seizures, Generalized Tonic-Clonic Seizure, Memory Loss, and Epilepsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Drappatz's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 11 Advanced Conditions
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile